Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-28 Sale |
2024-11-05 4:33 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,112 | $1.58 | $1,757 | 923,905 (Indirect Direct) |
View |
| 2024-04-08 Purchase |
2024-04-10 5:16 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
8,308 | $1.2313 | $10,229 | 1,005,007 (Indirect Direct) |
View |
| 2024-02-08 Purchase |
2024-02-12 09:26 am |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
160,000 | $1.2876 | $206,023 | 926,376 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-09 08:00 am |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
120,000 | $1.3521 | $162,255 | 766,376 (Indirect Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 4:32 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
250 | $1.877 | $469 | 646,376 (Indirect Direct) |
View |
| 2023-11-27 Sale |
2023-12-01 5:04 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
278 | $1.89 | $525 | 646,626 (Indirect Direct) |
View |
| 2023-09-14 Purchase |
2023-09-18 09:20 am |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
20,000 | $1.6 | $32,000 | 646,904 (Indirect Direct) |
View |
| 2023-09-15 Purchase |
2023-09-18 09:17 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
2,200 | $1.7 | $3,740 | 631,805 (Direct) |
View |
| 2023-07-28 Purchase |
2023-09-14 4:08 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
2,500 | $2.066 | $5,165 | 626,904 (Indirect Direct) |
View |
| 2023-09-13 Purchase |
2023-09-13 5:00 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
800 | $1.5325 | $1,226 | 630,405 (Direct) |
View |
| 2023-09-06 Purchase |
2023-09-06 5:53 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
2,887 | $1.96 | $5,659 | 629,605 (Direct) |
View |
| 2023-08-31 Purchase |
2023-08-31 1:54 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
4,954 | $2.22 | $10,998 | 619,160 (Indirect Direct) |
View |
| 2023-07-27 Purchase |
2023-07-28 11:17 am |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,000 | $2.8 | $2,800 | 307,432 (Direct) |
View |
| 2023-07-25 Purchase |
2023-07-25 5:56 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
4,200 | $2.44 | $10,248 | 626,718 (Direct) |
View |
| 2023-03-31 Purchase |
2023-04-04 07:00 am |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
747 | $3.56 | $2,659 | 614,206 (Indirect Direct) |
View |
| 2022-11-30 Purchase |
2023-03-03 4:11 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
6,200 | $2.8556 | $17,705 | 623,404 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 4:33 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
52,632 | $0 | 174,796 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 4:31 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
52,632 | $0 | 174,796 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 4:29 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
52,632 | $0 | 189,542 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 4:26 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
166,492 | $0 | 537,102 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 4:25 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
768,979 | $0 | 1,773,977 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 4:22 pm |
N/A 2035-02-14 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
791,885 | $0 | 1,844,653 (Direct) |
View |
| 2024-03-18 Tax Withholding |
2024-03-20 4:38 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
17,193 | $1.39 | 996,699 (Direct) |
View |
| 2024-03-18 Tax Withholding |
2024-03-20 4:36 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
17,633 | $1.39 | 1,052,768 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:27 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
79,646 | $0 | 122,164 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:25 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
79,646 | $0 | 122,164 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:23 pm |
N/A 2033-02-13 |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
79,646 | $0 | 136,910 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:19 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance |
219,298 | $0 | 316,543 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:17 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
263,158 | $0 | 370,610 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:13 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
394,737 | $0 | 1,013,896 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:11 pm |
N/A 2034-02-13 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
438,596 | $0 | 1,070,401 (Direct) |
View |
| 2023-03-20 Tax Withholding |
2023-03-22 4:49 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
6,729 | $2.92 | 613,459 (Direct) |
View |
| 2023-03-20 Tax Withholding |
2023-03-22 4:47 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
6,729 | $2.92 | 622,518 (Direct) |
View |
| 2023-02-18 Tax Withholding |
2023-02-28 07:26 am |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
374 | $2.99 | 620,188 (Direct) |
View |
| 2023-02-18 Tax Withholding |
2023-02-27 5:17 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
374 | $2.99 | 629,247 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 9:39 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance |
88,968 | $0 | 97,245 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 5:38 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
32,028 | $0 | 42,518 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 5:36 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
32,028 | $0 | 42,518 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 5:33 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
32,028 | $0 | 57,264 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 5:32 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
88,968 | $0 | 107,452 (Direct) |
View |